[Epidemiology of chronic glomerular diseases].
Chronic glomerular diseases are the cause of 35 to 55% of end-stage renal failure, according to countries or regions. In France, the estimated annual incidence of nondiabetic glomerular nephropathies is 82 per million population. IgA deposits, membranous and minimal change glomerulopathies, and focal and segmental glomerulosclerosis are the most common; crescent proliferative glomerulonephritis has the worse prognosis. Combined patient and kidney survival varies from 24 to 62% according to histologic types. Their incidence remains relatively stable in contrast with the constant rise of type 2 diabetic nephropathy. Over the 90s, the annual incidence rate of renal replacement therapy for end-stage renal failure due to diabetes doubled in Europe, reaching 10 to 50 per million population according to the country in Europe, and 144 per million population in the United States.
Stengel
Bénédicte
B
Inserm U. 258, Epidémiologie cardiovasculaire et métabolique, 94807 Villejuif Cedex. stengel@vjf.inserm.fr
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002908:Chronic Disease; D015331:Cohort Studies; D003928:Diabetic Nephropathies / Q000453:epidemiology; D005260:Female; D005602:France / Q000453:epidemiology; D005921:Glomerulonephritis / Q000150:complications / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology; D005922:Glomerulonephritis, IGA / Q000453:epidemiology; D015433:Glomerulonephritis, Membranous / Q000453:epidemiology; D005923:Glomerulosclerosis, Focal Segmental / Q000453:epidemiology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009402:Nephrosis, Lipoid / Q000453:epidemiology; D011379:Prognosis; D012737:Sex Factors; D014481:United States / Q000453:epidemiology